Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>

<p>Abstract</p> <p>Background</p> <p>Phenylpropanoids are the precursors to a range of important plant metabolites such as the cell wall constituent lignin and the secondary metabolites belonging to the flavonoid/stilbene class of compounds. The latter class of plant na...

Full description

Bibliographic Details
Main Authors: Schmidt-Dannert Claudia, Lee Pyung C, Watts Kevin T
Format: Article
Language:English
Published: BMC 2006-03-01
Series:BMC Biotechnology
Online Access:http://www.biomedcentral.com/1472-6750/6/22
_version_ 1811295567514435584
author Schmidt-Dannert Claudia
Lee Pyung C
Watts Kevin T
author_facet Schmidt-Dannert Claudia
Lee Pyung C
Watts Kevin T
author_sort Schmidt-Dannert Claudia
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Phenylpropanoids are the precursors to a range of important plant metabolites such as the cell wall constituent lignin and the secondary metabolites belonging to the flavonoid/stilbene class of compounds. The latter class of plant natural products has been shown to function in a wide range of biological activities. During the last few years an increasing number of health benefits have been associated with these compounds. In particular, they demonstrate potent antioxidant activity and the ability to selectively inhibit certain tyrosine kinases. Biosynthesis of many medicinally important plant secondary metabolites, including stilbenes, is frequently not very well understood and under tight spatial and temporal control, limiting their availability from plant sources. As an alternative, we sought to develop an approach for the biosynthesis of diverse stilbenes by engineered recombinant microbial cells.</p> <p>Results</p> <p>A pathway for stilbene biosynthesis was constructed in <it>Escherichia coli </it>with 4-coumaroyl CoA ligase 1 4CL1) from <it>Arabidopsis thaliana </it>and stilbene synthase (STS) cloned from <it>Arachis hypogaea</it>. <it>E. coli </it>cultures expressing these enzymes together converted the phenylpropionic acid precursor 4-coumaric acid, added to the growth medium, to the stilbene resveratrol (>100 mg/L). Caffeic acid, added in the same way, resulted in the production of the expected dihydroxylated stilbene, piceatannol (>10 mg/L). Ferulic acid, however, was not converted to the expected stilbene product, isorhapontigenin. Substitution of 4CL1 with a homologous enzyme, 4CL4, with a preference for ferulic acid over 4-coumaric acid, had no effect on the conversion of ferulic acid. Accumulation of tri- and tetraketide lactones from ferulic acid, regardless of the CoA-ligase expressed in <it>E. coli</it>, suggests that STS cannot properly accommodate and fold the tetraketide intermediate to the corresponding stilbene structure.</p> <p>Conclusion</p> <p>Phenylpropionic acids, such as 4-coumaric acid and caffeic acid, can be efficiently converted to stilbene compounds by recombinant <it>E. coli </it>cells expressing plant biosynthetic genes. Optimization of precursor conversion and cyclization of the bulky ferulic acid precursor by host metabolic engineering and protein engineering may afford the synthesis of even more structurally diverse stilbene compounds.</p>
first_indexed 2024-04-13T05:35:22Z
format Article
id doaj.art-f7df217dba6e4667a439448aa7c359df
institution Directory Open Access Journal
issn 1472-6750
language English
last_indexed 2024-04-13T05:35:22Z
publishDate 2006-03-01
publisher BMC
record_format Article
series BMC Biotechnology
spelling doaj.art-f7df217dba6e4667a439448aa7c359df2022-12-22T03:00:19ZengBMCBMC Biotechnology1472-67502006-03-01612210.1186/1472-6750-6-22Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>Schmidt-Dannert ClaudiaLee Pyung CWatts Kevin T<p>Abstract</p> <p>Background</p> <p>Phenylpropanoids are the precursors to a range of important plant metabolites such as the cell wall constituent lignin and the secondary metabolites belonging to the flavonoid/stilbene class of compounds. The latter class of plant natural products has been shown to function in a wide range of biological activities. During the last few years an increasing number of health benefits have been associated with these compounds. In particular, they demonstrate potent antioxidant activity and the ability to selectively inhibit certain tyrosine kinases. Biosynthesis of many medicinally important plant secondary metabolites, including stilbenes, is frequently not very well understood and under tight spatial and temporal control, limiting their availability from plant sources. As an alternative, we sought to develop an approach for the biosynthesis of diverse stilbenes by engineered recombinant microbial cells.</p> <p>Results</p> <p>A pathway for stilbene biosynthesis was constructed in <it>Escherichia coli </it>with 4-coumaroyl CoA ligase 1 4CL1) from <it>Arabidopsis thaliana </it>and stilbene synthase (STS) cloned from <it>Arachis hypogaea</it>. <it>E. coli </it>cultures expressing these enzymes together converted the phenylpropionic acid precursor 4-coumaric acid, added to the growth medium, to the stilbene resveratrol (>100 mg/L). Caffeic acid, added in the same way, resulted in the production of the expected dihydroxylated stilbene, piceatannol (>10 mg/L). Ferulic acid, however, was not converted to the expected stilbene product, isorhapontigenin. Substitution of 4CL1 with a homologous enzyme, 4CL4, with a preference for ferulic acid over 4-coumaric acid, had no effect on the conversion of ferulic acid. Accumulation of tri- and tetraketide lactones from ferulic acid, regardless of the CoA-ligase expressed in <it>E. coli</it>, suggests that STS cannot properly accommodate and fold the tetraketide intermediate to the corresponding stilbene structure.</p> <p>Conclusion</p> <p>Phenylpropionic acids, such as 4-coumaric acid and caffeic acid, can be efficiently converted to stilbene compounds by recombinant <it>E. coli </it>cells expressing plant biosynthetic genes. Optimization of precursor conversion and cyclization of the bulky ferulic acid precursor by host metabolic engineering and protein engineering may afford the synthesis of even more structurally diverse stilbene compounds.</p>http://www.biomedcentral.com/1472-6750/6/22
spellingShingle Schmidt-Dannert Claudia
Lee Pyung C
Watts Kevin T
Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
BMC Biotechnology
title Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
title_full Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
title_fullStr Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
title_full_unstemmed Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
title_short Biosynthesis of plant-specific stilbene polyketides in metabolically engineered <it>Escherichia coli</it>
title_sort biosynthesis of plant specific stilbene polyketides in metabolically engineered it escherichia coli it
url http://www.biomedcentral.com/1472-6750/6/22
work_keys_str_mv AT schmidtdannertclaudia biosynthesisofplantspecificstilbenepolyketidesinmetabolicallyengineereditescherichiacoliit
AT leepyungc biosynthesisofplantspecificstilbenepolyketidesinmetabolicallyengineereditescherichiacoliit
AT wattskevint biosynthesisofplantspecificstilbenepolyketidesinmetabolicallyengineereditescherichiacoliit